CACLP - The largest IVD Expo & Conference

Abbott-Alere One Year Later: Was It Worth All the Fuss?

Industry news | 01 November, 2018 | CACLP
It's hard to believe it's been a full year since Abbott closed its acquisition of Alere, considering what a contentious deal it was and how hard Abbott fought last year to get out of it. When the acquisition finally did close, Will All the Abbott-Alere Fuss Be Worth It?
 
To be fair, it's probably too soon to completely tackle that question just yet. Still, given that a year has elapsed since the deal closed on Oct. 3, 2017, it makes sense to at least look at where the company stands today with regard to Alere, which Abbott refers to now as its rapid diagnostics business.
 
CFO Brian Yoor said during the company's third-quarter earnings call on Wednesday that the rapid diagnostics business is on track to contribute sales of a little more than $2 billion this year, and about $500 million of that is expected in the fourth quarter.

But for the most part, Abbott's focus during this past year with regard to Alere has been on stabilizing, integrating, organizing, and putting management into place, CEO Miles White said during the call.

"I think we're mostly through all the disruption and/or transition, synergies, et cetera," White said. "And at this point, our entire emphasis turns to what kind of sustainable growth rate we can now generate and trend out of that business."

White doesn't yet have a specific answer to that question, but he said he does anticipate that Alere assets will contribute to Abbott's growth in the future. He also said the infectious disease testing business that was part of Alere benefited last year from "probably one of the stronger flu seasons in a long time."

At the time of closing, Abbott said the acquisition gave the company a leading position in point-of-care testing, which is a fast-growing, $7 billion segment of the $50 billion in vitro diagnostics market. The company also noted at the time that many healthcare systems are upping their reliance on these technologies to inform patient care decisions with easy-to-use tests that provide speed and accuracy, particularly in the outpatient setting.
Press contact CACLP - The largest IVD Expo & Conference

Stay in touch with CACLP News

We deliver the latest IVD news straight to your inbox. Stay in touch with CACLP News, sign-up for our newsletter today.

  • Name *
  • Email *
  • Company name *
  • Country *
    CACLP - The largest IVD Expo & Conference

By subscribing our newsletter, you agree to our Privacy Policy. You can unsubscribe at anytime.

Share
Opening Countdown
0 0 0

Day(s)

0 0

Hour(s)

0 0

Min(s)

Room 2201-2203 & 2205, Cloud Nine Plaza
1118 West Yan’an Road
Shanghai, China
200052

Copyright © 2024 GL events Ruihe (Shanghai) Exhibition Co., Ltd. All Rights Reserved. ( 沪ICP备12004745号-1 )

We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy & Cookies for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

CACLP - The largest IVD Expo & Conference